In this review, we focus on recent studies that elucidate how miRs negatively impact hepatic AMPK, either directly or indirectly, and discuss the mechanisms that underlie the aberrant increase in the expression of some miR genes that can impact AMPK function in obesity and NAFLD. Here, PRKAB1 is linked to metabolic dysfunction-associated steatotic liver disease.